CEACAM5 and cancer: Healthy control subjects (N=133) and COPD patients (N=30) showed a normal median expression of CA-62 cancer antigen (2,667 U/mL and 2,664 U/mL) and CEA antigen (2.2 ng/mL and 2.4 ng/mL).